Accenture plc

Accenture’s most recent 10-Q presents a concise view, with Item 7, Management’s Discussion and Analysis, noting “no material changes to the information on market risk exposure” during the six months ended February 28, 2026. This suggests a stable environment from management’s perspective regarding market fluctuations. The filing also highlights “Off-Balance Sheet Arrangements” where the company may indemnify clients, directing readers to Note 11 for further details, which are not provided in the excerpt.

The forensic scores offer a mixed, though generally reassuring, quantitative perspective. Beneish’s 1999 eight-ratio earnings-manipulation detector yielded an M-Score of -2.5869, which is below the -1.78 threshold, indicating no elevated risk of earnings manipulation. Altman’s Z″ — a 1968 bankruptcy-distress index — registered 2.06. This places the company in the 1.10–2.60 “grey zone,” suggesting neither clear financial safety nor imminent distress based on this metric. Piotroski’s F-Score, a 9-point fundamental strength scan, and the Fog Index, a readability score, were not available for this filing.

Within Item 7, the discussion of “Off-Balance Sheet Arrangements” merits attention. The company acknowledges contractual obligations to indemnify clients but states that “we have not been required to make any significant payment under any of the arrangements described above” to date. While this indicates a lack of historical impact, the potential for future obligations remains, and without the referenced Note 11, the full scope of these contingent liabilities is not ascertainable from the provided excerpts.

This reading of the 10-Q provides a snapshot of Accenture’s financial health and disclosure practices based on the available data. The Beneish M-Score suggests accounting integrity, and the Altman Z″ places the company in a neutral zone, while the brevity of the MD&A implies stability. However, the absence of a Piotroski F-Score and Fog Index, coupled with the lack of detailed financial notes, limits a comprehensive assessment of fundamental strength or disclosure clarity. This filing describes the company’s reported condition, not the security’s market valuation.